HomeNewsNaproxen sodium tablets

Naproxen Sodium Tablets

Jump to

Aurobindo Pharma climbs after USFDA nod for OTC drug

"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Naproxen Sodium tablets USP, 220 mg," Aurobindo Pharma had said in a BSE filing on Saturday.
Aurobindo Pharma gets USFDA nod for osteoporosis drug

"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Naproxen Sodium tablets USP, 220 mg," Aurobindo Pharma said in a BSE filing.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Naproxen Sodium Tablets

Aurobindo Pharma climbs after USFDA nod for OTC drug

Aurobindo Pharma gets USFDA nod for osteoporosis drug